Blogs

How You can Use Risk-Based Monitoring (RBM) to Boost Clinical Trial Outcomes

How You can Use Risk-Based Monitoring (RBM) to Boost Clinical Trial Outcomes

According to estimates, traditional onsite monitoring today accounts for almost 33% of the life sciences industry’s $30bn-plus clinical trial spend.

28 Jun 2017

7 major trends shaping clinical trials: Implications for Life Sciences companies

7 major trends shaping clinical trials: Implications for Life Sciences companies

The going is certainly getting tougher for life sciences companies. The industry today faces rising pressure from consumers and policy makers to lower drug prices, reduce time-to-market for new products, and comply with increasingly onerous regulations.

30 May 2017

Toward Faster and Cheaper Trials: Three Ways You can Improve Clinical Data Accuracy

Toward Faster and Cheaper Trials: Three Ways You can Improve Clinical Data Accuracy

As many as five out of 10 clinical trials fail to make it past phase three of research, even as it costs almost $40m–around 50% of the average trial budget–to reach that stage.

25 May 2017

Three Ways CROs Can Boost Clinical Trial Efficiency

Three Ways CROs Can Boost Clinical Trial Efficiency

Declining R&D productivity, soaring product development costs, growing complexity of trial protocols, and rising regulatory submissions are prompting pharmaceutical, biotechnology and medical device companies to outsource research services.

25 May 2017

CONTACT US TODAY

Get daily updates in your inbox

Watch: How we add value

Want to know more? Talk to us.

Contact us+1-408-387-5800